CD69 expression revealed that, in response to IL-2 stimulation and K562 target cell interaction, NK cells from patients with RA in stable remission exhibited levels of activation like healthy controls, while NK cells from patients with RA with active disease displayed elevated levels of activation (Figure 4B). This evidence concerns the gene CD69 and rheumatoid arthritis.